Patent details

Herbas

VPB

Print

EN | LT

LT - BENZAMIDE DERIVATIVES FOR INHIBITING THE ACTIVITY OF ABL1, ABL2 AND BCR-ABL1

EN - BENZAMIDE DERIVATIVES FOR INHIBITING THE ACTIVITY OF ABL1, ABL2 AND BCR-ABL1

Legal status

Patent not validated

Bibliographic data

Indications of the International Patent Classification (IPC)
(51)	INT.CL.	C07D 401/04
		C07D 401/14
		C07D 403/10
		C07D 405/14
		C07D 409/14
		C07D 413/14
		C07D 417/10
		C07D 417/14
		A61K 31/4439
		A61K 31/444
		A61K 31/496
		A61K 31/5377
		A61P 31/00

European patent
(11)	Number of the document	2861576
(13)	Kind of document	T
(96)	European patent application number	13730655.1
	Date of filing the European patent application	2013-05-09
(97)	Date of publication of the European application	2015-04-22
(45)	Date of publication and mention of the grant of the patent	2018-01-10
(46)	Date of publication of the claims translation

PCT application
(86)	Number	PCT/IB2013/053771
	Date	2013-05-09

PCT application publication
(87)	Number	WO 2013/171642
	Date	2013-11-21

Priority applications
(30)	Number	Date	Country code
	201261647174 P	2012-05-15	US
	201361789842 P	2013-03-15	US

Inventors
(72)	FURET, Pascal, CH GROTZFELD, Robert Martin, CH JONES, Darryl Brynley, CH MANLEY, Paul, CH MARZINZIK, Andreas, CH PELLE, Xavier Francois Andre, CH SALEM, Bahaa, CH SCHOEPFER, Joseph, CH JAHNKE, Wolfgang, CH

Grantee
(73)	Novartis AG, Lichtstrasse 35, 4056 Basel, CH

Title
(54)	BENZAMIDE DERIVATIVES FOR INHIBITING THE ACTIVITY OF ABL1, ABL2 AND BCR-ABL1
	BENZAMIDE DERIVATIVES FOR INHIBITING THE ACTIVITY OF ABL1, ABL2 AND BCR-ABL1